Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02068469 · ClinicalTrials.gov registry record

In Vitro Diagnostic Device for the Detection of Strep A

A clinical trial, sponsored by IQuum.

Completed
Registry status
799
Enrollment target

NCT02068469: Completed study, sponsored by IQuum.

NCT02068469 is a clinical trial that has completed, run by IQuum. The registered enrollment target is 799 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02068469 has completed, sponsored by IQuum.

COMPLETED
Registry status
799 participants
Enrollment target

Study Summary

The purpose of this trial is to show the accuracy and specificity of the Liat analyzer and assay for detecting Strep A at the point of care lab compared to culture.

Trial Details

FieldValue
Enrollment Target 799 participants
Start Date 2013-12
Est. Completion 2014-04
IQuum

2 total trials

What the finished NCT02068469 record still lists

NCT02068469 is an observational study that tracks outcomes without assigning an intervention. The registered 799 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02068469 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02068469 about?

NCT02068469 is a clinical study titled "In Vitro Diagnostic Device for the Detection of Strep A". The purpose of this trial is to show the accuracy and specificity of the Liat analyzer and assay for detecting Strep A at the point of care lab compared to culture.

What is the current status of trial NCT02068469?

This trial is currently completed. The enrollment target is 799 participants. The study started on 2013-12. Estimated completion is 2014-04.

Who is sponsoring clinical trial NCT02068469?

This trial is sponsored by IQuum, which has 2 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02068469, the US trial registry maintained by the National Library of Medicine. NCT02068469 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.